Amgen picks Naveen Gullapalli to helm India tech & innovation hub in Hyderabad

HYDERABAD: Lifesciences giant Amgen, which is setting up its global capability centre (GCC) in Hyderabad, has appointed former Novartis senior executive, Naveen Gullapalli, as managing director of Amgen India.
Gullapalli will lead the Amgen India Technology and Innovation site in Hyderabad leveraging his extensive experience in leading global operations and adjoining functions across the pharmaceutical, finance and technology industries, Amgen said on Wednesday.
At Novartis Gullapalli led the development of the pharma giant’s global center in Hyderabad and helmed their network of six centers across the world where he was instrumental in driving strategic growth and innovation for the enterprise.
“His deep experience in developing specialized skills and enabling business transformation aligns closely with Amgen’s vision for its Hyderabad site as a global technology and innovation hub,” the company said.
"Amgen India is key to furthering our global vision of unlocking the convergence of biotech and tech to accelerate innovation and help meet the needs of a globally aging population. Naveen’s wealth of experience and strategic leadership will drive the success of this new site,” said Som Chattopadhyay, national executive for India at Amgen.
“India’s talent pool offers a compelling opportunity for Amgen to deliver world-class functional excellence, operational excellence, innovation and technology-led transformation. I am excited for this opportunity to advance tech from India in order to serve more patients globally,” said Naveen Gullapalli.